Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > New design of bioactive peptide nanofibers keeping both temperature reversibility and stiffness control

Temperature response of the peptide. It forms solid (gel) at 20 degree Celsius and liquid (sol) at 80 degree Celsius indicated by white brackets, and this feature is reversible.

CREDIT
Takahiro Muraoka, TUAT
Temperature response of the peptide. It forms solid (gel) at 20 degree Celsius and liquid (sol) at 80 degree Celsius indicated by white brackets, and this feature is reversible. CREDIT Takahiro Muraoka, TUAT

Abstract:
A collaboration mainly led by scientists from Tokyo University of Agriculture and Technology (TUAT) in Japan has developed a new method of molecular design to control both temperature reversibility and stiffness of nanofibers that are gel-forming peptides. The peptide nanofiber hydrogel can be used as biomedical materials. This method will allow the peptide nanofibers more biomedical applicable.

New design of bioactive peptide nanofibers keeping both temperature reversibility and stiffness control

Tokyo, Japan | Posted on September 30th, 2019

The researchers published their results on July 8th in Chemistry-A European Journal, which was highlighted in the Front Cover and Cover Profile.

In general, some of peptides form nanofiber hydrogels. These peptides are short chains of natural amino acids found in all living organisms. Since these are bio-friendly, these have been widely used in medicine such as tissue recovery materials, regenerative medical materials, extracellular matrices, cell culture materials, and drug delivery containers.

"For some medical applications of nanofiber peptides, we need to develop a technique to control both stiffness (mechanical strength) and temperature response changing between gel (solid) and sol (liquid)," said Takahiro Muraoka, PhD, corresponding author on the paper and associate professor in the Department of Applied Chemistry, Graduate School of Engineering at TUAT. "It is, however, difficult to make better the both features at the same time. For example, when increasing stiffness of a peptide nanofiber by replacement of a simple amino acid alanine to a more hydrophobic amino acid phenylalanine, it is known that temperature response is often lost."

In their experiments, they found that an amino acid replacement that was thought to make a softer gel unexpectedly formed a harder gel. They used 5 sets of different peptides that had 16 amino acids. Interestingly, one particular peptide did not lose temperature response. The peptide (concentration at 1% in solution) formed gel (solid) at 20°C (68°F) and when increasing temperature to 80°C (178°F) the gel became sol (liquid). When reducing temperature from 80°C to 20°C, gel was again formed. "This temperature reversible feature is applicable for drug delivery by local injection," said Muraoka.

They replaced alanine in the middle of the peptide to glycine, the simplest amino acid. The glycine replacement usually makes the gel softer. They used regular analytical instrument such as CD, IR, and TEM microscopy to understand precisely how the gel was formed. They also used a computational approach, called molecular dynamics simulation. "Based on our results, we are now able to design peptides better by computer simulation," said Muraoka.

Furthermore, the peptide nanofiber was cell adhesive, which is suitable as a biomaterial for cell culture and tissue regeneration. "This research will open new avenues towards designing peptide nanofibers more biomedical applicable," Muraoka added.

####

About Tokyo University of Agriculture and Technology
TUAT is a distinguished university in Japan dedicated to science and technology. TUAT focuses on agriculture and engineering that form the foundation of industry, and promotes education and research fields that incorporate them. Boasting a history of over 140 years since our founding in 1874, TUAT continues to boldly take on new challenges and steadily promote fields. With high ethics, TUAT fulfills social responsibility in the capacity of transmitting science and technology information towards the construction of a sustainable society where both human beings and nature can thrive in a symbiotic relationship.

For more information, please click here

Contacts:
Yutaka Nibu, Ph.D.

81-423-887-550

Takahiro Muraoka, PhD.
Associate Professor
Department of Applied Chemistry, Graduate School of Engineering, TUAT, Japan.

Copyright © Tokyo University of Agriculture and Technology

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related Links

Original publication:

For more information about the Muraoka laboratory, please visit:

Related News Press

News and information

Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024

Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Possible Futures

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

Nanomedicine

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery: NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery September 13th, 2024

Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024

Nanobody inhibits metastasis of breast tumor cells to lung in mice: “In the present study we describe the development of an inhibitory nanobody directed against an extracellular epitope present in the native V-ATPase c subunit.” August 16th, 2024

Discoveries

Breaking carbon–hydrogen bonds to make complex molecules November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

Announcements

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters

Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024

Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Nanobiotechnology

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery: NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery September 13th, 2024

Nanobody inhibits metastasis of breast tumor cells to lung in mice: “In the present study we describe the development of an inhibitory nanobody directed against an extracellular epitope present in the native V-ATPase c subunit.” August 16th, 2024

The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project